Evidence map›Paper›PMID 41205093›Full record

ReviewWorld journal of microbiology & biotechnology2025

Emerging green-synthesized nanozymes for microbial applications: toward sustainable antimicrobial technologies.

Lovepreet Singh, Aparajita Sharma, Jagdish Verma

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lovepreet SinghDepartment of Chemical Engineering, Thapar Institute of Engineering and Technology, Patiala, 147004, India. lovepreet.singh@thapar.edu.
Aparajita SharmaUniversity School of Allied Health Science, Rayat Bahra University, Greater Mohali, 140301, India. aparajita.18.sharma@gmail.com.
Jagdish VermaFaculty of Applied Science and Biotechnology, Shoolini University, Solan, 173229, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green-synthesized nanozymes represent a transformative approach to microbial control, integrating sustainability with advanced nano-catalytic function. These nanozymes exhibit remarkable enzyme-like activity, including oxidase, peroxidase, and catalase mimetic properties, enabling effective antimicrobial action via reactive oxygen species (ROS) generation, metal ion release, and biofilm disruption. Their synthesis through plant, microbial, algal, and waste-derived methods reduces toxicity and environmental impact while enhancing biocompatibility and cost-effectiveness. Applications in clinical therapies, food and water decontamination, and environmental remediation demonstrate their vast potential. Despite these promising attributes, green nanozymes still face challenges such as inconsistent catalytic efficiency, scalability, and limited substrate specificity. Future innovations must prioritize mechanistic understanding, atomic-level design, and AI-assisted synthesis to improve selectivity and reproducibility. Regulatory clarity and eco-toxicological evaluations will be critical for their clinical and commercial translation. Overall, green-synthesized nanozymes hold the promise to redefine antimicrobial strategies, offering multifunctional, low-carbon solutions aligned with the global sustainability agenda.

Indexed as

Anti-Infective AgentsGreen Chemistry TechnologyNanostructuresBacteriaBiofilmsCatalysisHumansReactive Oxygen SpeciesAnti-Infective AgentsReactive Oxygen SpeciesAntimicrobial activityGreen synthesisMicrobial controlNanozymesReactive oxygen species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.